期刊文献+

PPARα转基因小鼠在药物毒性评价中的应用 被引量:2

Application of PPARα transgenic mice in the evaluation of drug toxicity
下载PDF
导出
摘要 目的研究PPARα转基因小鼠在评价PPARα激动剂类药物毒性时,是否比传统动物更敏感。方法8周龄PPARα转基因小鼠(Tg)和C57BL/6J小鼠(WT),雌雄各半,分别随机分成3组,氯贝丁酯高剂量组(400 mg/kg)、氯贝丁酯低剂量组(300 mg/kg)、溶媒对照组(10%羧甲基纤维素钠)。连续灌胃一个月,给药结束后检测血生化指标、心肝肾脏器系数及病理改变,并观察动物的一般生长情况。结果 1血生化:Tg♂高、低剂量组肌酐(CREA)、天门冬氨酸氨基转移酶(AST)分别显著高于各对应的野生型对照组(P<0.01,P<0.05)。2脏器系数:Tg高、低剂量组肾脏系数与Tg溶媒对照组比较均有显著增加(P<0.01,P<0.05)。3组织病理:Tg各剂量组肝脏、肾脏病理损伤较WT各剂量组更严重。结论 PPARα转基因小鼠评价PPARα激动剂药物肝脏毒性和肾脏毒性时比常规C57BL/6J野生小鼠更敏感,是一个新的动物模型。 Objective To explore whether PPARα transgenic mice are more sensitive animal models in the evaluation of toxicity of PPARα agonists. Methods Twenty-eight 8-week old PPARα transgenic mice( Tg) and 28 C57 BL /6J mice( WT) with half males and half females were randomly divided into high dose group( 400 mg / kg of clofibrate),low dose group( 30 mg / kg of clofibrate) and solvent control group( 10% sodium carboxymethyl cellulose). The time of gavage administration lasted 28 days. The blood biochemistry,organ coefficient and pathological changes of the heart,liver,kidney were tested after the drug administration. The growth of mice was also recorded. Results 1Blood biochemistry: Compared with the WT male administration group,in the Tg male administration group,the levels of blood creatinine( CREA)and aspartate aminotransferase( AST) were markedly increased( P < 0. 01,P < 0. 05). 2 Organ coefficient: Compared with the Tg control group,the kidney coefficients of Tg administration group were significantly increased( P < 0. 01,P <0. 05). 3Histopathology: Compared with the WT administration group,the pathological damages of liver and kidney were more serious in the Tg administration group. Conclusions Compared with C57 BL /6J mouse,PPARα transgenic mice are more sensitive in evaluation of hepatotoxicity and nephrotoxicity of PPARα agonists. It is a new animal model.
出处 《中国实验动物学报》 CAS CSCD 北大核心 2015年第3期316-320,共5页 Acta Laboratorium Animalis Scientia Sinica
基金 国家十二五重大新药创制专项(2013ZX09302302-002)
关键词 PPARα转基因小鼠 PPARΑ激动剂 肝毒性 肾毒性 PPARα transgenic mouse PPARα agonist Hepatotoxicity Nephrotoxicity
  • 相关文献

参考文献13

  • 1Kersten S,Desvergne B,Wahli W.Roles of PPARs in health and disease. Nature . 2000
  • 2Bensinger Steven J,Tontonoz Peter.Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature . 2008
  • 3Everett L,Galli A,Grabb D.The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease. Liver . 2000
  • 4Boverhof Darrell R,Zacharewski Timothy R.Toxicogenomics in risk assessment: applications and needs. Toxicological sciences : an official journal of the Society of Toxicology . 2005
  • 5Damsgaard T,Clausen N,West-Nielsen E,Lyngbye J.Early diagnosis of acute myocardial infarction by means of aspartate aminotransferase, creatine kinase and creatine kinase isoenzyme MB. Danish Medical Bulletin . 1979
  • 6Tsuyoshi Goto,Nobuyuki Takahashi,Sota Kato,Kahori Egawa,Shogo Ebisu,Tatsuya Moriyama,Tohru Fushiki,Teruo Kawada.Phytol directly activates peroxisome proliferator-activated receptor α (PPARα) and regulates gene expression involved in lipid metabolism in PPARα-expressing HepG2 hepatocytes[J]. Biochemical and Biophysical Research Communications . 2005 (2)
  • 7Longxin Qiu,Hong Ye,Limei Chen,Yamin Hong,Fojin Zhong,Tingting Zhang.Red Clover Extract Ameliorates Dyslipidemia in Streptozotocin‐induced Diabetic C57BL/6 Mice by Activating Hepatic PPARα[J]. Phytother. Res. . 2011 (6)
  • 8Daniel H. van Raalte,Min Li,P. Haydn Pritchard,Kishor M. Wasan.Peroxisome Proliferator-Activated Receptor (PPAR)-α: A Pharmacological Target with a Promising Future[J]. Pharmaceutical Research . 2004 (9)
  • 9张峻,综述,戴宇飞,审校.转基因动物模型在毒理学中的应用[J].卫生研究,2012,41(5):868-873. 被引量:2
  • 10李兰芳,李国风,解丽君.大、小鼠口服腰痛宁胶囊的急性毒性研究[J].实验动物科学与管理,2004,21(4):12-15. 被引量:7

二级参考文献69

  • 1高爱滨,肖谦.PPARα与非酒精性脂肪肝[J].国际消化病杂志,2007,27(1):18-21. 被引量:9
  • 2计福全.腰痛宁胶囊临床疗效及特点[J].中草药,1997,28(2):125-125. 被引量:10
  • 3徐叔云,卞如莲,陈修.药理实验方法学.第二版,北京:人民卫生出版社.1991.201-206.
  • 4周立国.药物毒理学.武汉:湖北科学技术出版社,2001,23:9.
  • 5秦伯益主编.新药评价概论.北京:人民卫生出版社,1999.181.
  • 6JAENISCH R,MINTZ B.Simian virus 40 DNA sequences inDNA of healthy adult mice derived from preimplantationblastocysts injected with viral DNA[J].Proc Natl Acad Sci U SA,1974,71:1250-1254.
  • 7JAENISCH R.Germ line integration and Mendelian transmissionof the exogenous Moloney leukemia virus[J].Proc Natl Acad SciUSA,1976,73:1260-1264.
  • 8GORDON J W,SCANGOS G A,PLOTKIN D J,et al.Genetictransformation of mouse embryos by microin-jection of purifiedDNA[J].Proc Natl Acad Sci USA,1980,77:7380-7384.
  • 9GAMA SOSA M A,DE GASPERI R,ELDER G A.Animaltransgenesis:an overview[J].Brain Struct Funct,2010,214:91-109.
  • 10YOKOHIRA M,ARNOLD L L,PENNINGTON K L,et al.Severesystemic toxicity and urinary bladder cytoto-xicity andregenerative hyperplasia induced by arsenite in arsenic(+3oxidation state)methyltransferase knoc-kout mice.A preliminaryreport[J].Toxicol Appl Pharmacol,2010,246:1-7.

共引文献60

同被引文献51

  • 1谭亚夏,韩文玲,陈英玉,欧阳能太,唐岩,李枫,丁培国,任筱兰,曾广翘,丁静,朱彤,马大龙,钟南山.Chemokine-like factor 1,a novel cytokine,contributes to airway damage,remodeling and pulmonary fibrosis[J].Chinese Medical Journal,2004(8):1123-1129. 被引量:31
  • 2吕培志,齐洋,李天翥.天麻素注射液药理毒理研究综述[J].黑龙江医药,2006,19(4):297-299. 被引量:7
  • 3何晶.天麻素的药理作用及临床应用[J].天津药学,2006,18(5):62-63. 被引量:80
  • 4贾宝贤,左增艳.天麻药材粉对高脂小鼠降血脂和降血糖作用研究[J].医学信息,2013,26(8):589-590.
  • 5Qu LL,Yu B,Li Z,et al. Gastrodin ameliorates oxidative stress and proinflammatory response in nonalcoholic fatty liver disease through the AMPK/Nrf2 pathway [J]. PhytotherRes,2016,30(3):402-411.
  • 6Kim KJ,Lee OH,Han CK,et al. Acidic polysaccharide extracts from gastrodia rhizomes suppress the atheroscle- rosis risk index through inhibition of the serum choles- terol composition in sprague dawley rats fed a high-fat diet [J]. Int J Mol Sci,2012,13(2):1620-1631.
  • 7Lee OH,Kim KI,Han CK,et al. Effects of acidic polysac- charides from gastrodia rhizome on systolic blood pres- sure and serum lipid concentrations in spontaneously hy- pertensive rats fed a high-fat diet [J]. Int J Mol Sci,2012, 13(1 ) :698-709.
  • 8Fan JG,Farrell GC. Epidemiology of non--alcoholic fatty liver disease in China [J]. J Hepatol, 2009,50( 1):204-210.
  • 9于滨,孔维佳,左增艳,等.天麻和天麻素在制备治疗非酒精性脂肪肝的产品的应用:中国,CN103566198A[P].2014-02-12.
  • 10Nienaber-Rousseau C, Ellis SM, Moss SJ,et al. Gene- environment and gene-gene interactions of specific MTHFR, MTR and CBS gene variants in relation to ho- mocysteine in black South Africans [J]. Gene,2013,530 (1):113-118.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部